NS Wind Down Co Inc. (NSTGQ)
Market Cap | 3.31M |
Revenue (ttm) | 162.47M |
Net Income (ttm) | -166.43M |
Shares Out | 48.12M |
EPS (ttm) | -3.53 |
PE Ratio | n/a |
Forward PE | n/a |
Dividend | n/a |
Ex-Dividend Date | n/a |
Volume | 37,329 |
Open | 0.0710 |
Previous Close | 0.0715 |
Day's Range | 0.0675 - 0.0710 |
52-Week Range | 0.0400 - 5.1800 |
Beta | n/a |
Analysts | n/a |
Price Target | n/a |
Earnings Date | n/a |
About NSTGQ
NS Wind Down Co., Inc. develops, manufactures, and sells technology for scientific and clinical information in the fields of genomics and proteomics in the Americas, Europe, the Middle East, and the Asia Pacific. The company offers nCounter Analysis System, an automated, multi-application, digital detection, and counting system. It provides nCounter Pro and FLEX systems that include Prep Station, an automated liquid handling component that processes and prepares samples for data collection; and nCounter Digital Analyzer, which collects data fro... [Read more]
Financial Performance
In 2022, NSTGQ's revenue was $127.26 million, a decrease of -12.28% compared to the previous year's $145.09 million. Losses were -$159.54 million, 38.4% more than in 2021.
Financial StatementsNews
Seattle biotech company NanoString to be acquired by Bruker for $392M, ending bankruptcy process
NanoString announced Wednesday that it will be acquired by Bruker, ending the company's restructuring process that included a Chapter 11 bankruptcy plan.
NanoString Technologies to Be Acquired by Bruker Corporation
SEATTLE--(BUSINESS WIRE)--NanoString Technologies, Inc. (“NanoString” or “the Company”), a leading provider of life science tools for discovery and translational research, today announced that substan...
NanoString Products Drive Breakthrough Cancer Research at the 2024 American Association of Cancer Research (AACR) Conference
SEATTLE--(BUSINESS WIRE)-- #AACR24--NanoString Technologies, Inc., a leading provider of life science tools for discovery and translational research, will present at the 2024 meeting of the American A...
Healthcare investment firm Patient Square Capital agrees to acquire NanoString assets for $220M
NanoString, the Seattle-based biotech company that initiated a Chapter 11 bankruptcy process last month, announced late Sunday it agreed to a deal with healthcare investment firm Patient Square Capita...
Patient Square Capital, a Leading Health Care-Focused Investment Firm, Agrees to Acquire NanoString Technologies
SEATTLE--(BUSINESS WIRE)-- #AGBT2024--NanoString Technologies, Inc. (OTC: NSTGQ) (“NanoString” or the “Company”), a leading provider of life science tools for discovery and translational research, tod...
European UPC Court of Appeal Overturns Injunction Impacting NanoString's CosMx Products, Company to Immediately Resume Sales in 16 EU Countries
SEATTLE--(BUSINESS WIRE)--NanoString Technologies, Inc. (OTC: NSTGQ) (“NanoString”), a leading provider of life science tools for discovery and translational research, today announced that the Europea...
NanoString Announces Completion of Financing to Support Restructuring Process
SEATTLE--(BUSINESS WIRE)--NanoString Technologies, Inc. (NASDAQ: NSTG), a leading provider of life science tools for discovery and translational research, today announced the Company has entered into ...
NanoString stock sinks 70% as Seattle biotech company enters bankruptcy process
Seattle-based publicly traded biotech company NanoString Technologies announced Monday that it has initiated a Chapter 11 bankruptcy plan and is exploring a potential sale in the latest fallout from i...
NanoString Takes Steps to Restructure Its Business and Protect Its Mission to Map the Universe of Biology
SEATTLE--(BUSINESS WIRE)--NanoString Technologies, Inc. (NASDAQ: NSTG) (“NanoString” or “the Company”), a leading provider of life science tools for discovery and translational research, today announc...
NanoString Launches the CosMx 6,000 plex RNA Assay and Showcases Whole Transcriptome Imaging Capability
SEATTLE--(BUSINESS WIRE)-- #AGBT2024--NanoString Technologies, Inc. (NASDAQ: NSTG), a leading provider of life science tools for discovery and translational research, today announced the commercial av...
NanoString's CosMx SMI Achieves Whole Transcriptome Imaging at Single-Cell Resolution
SEATTLE--(BUSINESS WIRE)--NanoString Technologies, Inc. (NASDAQ: NSTG), a leading provider of life science tools for discovery and translational research, today announced the release of the first publ...
NanoString Technologies to cut 9% of workforce, gets delisting notice from Nasdaq
Seattle-based publicly traded biotech company NanoString Technologies said in a filing Friday that it plans to cut about 50 positions, or 9% of its workforce.
NanoString Reports Inducement Grants Under Nasdaq Listing Rules
SEATTLE--(BUSINESS WIRE)--NanoString Technologies, Inc. (Nasdaq: NSTG), a leading provider of life science tools for discovery and translational research, today announced, as required by Nasdaq Stock ...
NanoString to Webcast Presentation from 42nd Annual J.P. Morgan Healthcare Conference
SEATTLE--(BUSINESS WIRE)--NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for discovery and translational research, today announced that company management is sch...
NanoString stock sinks nearly 50% after losing patent lawsuit case against 10x Genomics
Shares of Seattle-based publicly traded biotech company NanoString Technologies fell nearly 50% to an all-time low on Monday following its loss in a patent infringement case against 10x Genomics.
NanoString Comments on Delaware District Court Verdict
SEATTLE--(BUSINESS WIRE)--NanoString Comments on Delaware District Court Verdict.
10x Genomics Wins Another Patent Infringement Case Against NanoString Technologies
Jury Awards 10x Genomics Over $31 Million in Damages and Finds All Seven Asserted Patents Valid and Willfully Infringed by NanoString GeoMx Decision is Third Ruling Against NanoString, Showing Serial ...
NanoString Technologies to Present Portfolio of Cutting-edge Brain Research and Novel Spatial Biology Applications for Neuroscience
SEATTLE--(BUSINESS WIRE)--NanoString will present at the Society for Neuroscience meeting new brain research powered by its spatial profiling and spatial imaging platforms.
NanoString to Webcast Presentations from Upcoming Healthcare Conferences
SEATTLE--(BUSINESS WIRE)--NanoString to present at November conferences.
NanoString Technologies Releases Operating Results for Third Quarter of 2023
SEATTLE--(BUSINESS WIRE)-- #earnings--NanoString reports Q3 2023 Operating Results.
NanoString Customers Present First Data Using the Most Comprehensive Spatial Proteomics Panel Available
SEATTLE--(BUSINESS WIRE)--NanoString Technologies, a leading provider of life sciences tools for discovery and translational research, announced today the line-up of researchers joining NanoString at ...
10x Genomics Comments on Second UPC Preliminary Injunction Decision
UPC Denies Second Preliminary Injunction Request; Prior Injunctions Against NanoString's CosMx Products in Europe Remain in Full Effect PLEASANTON, Calif. , Oct. 10, 2023 /PRNewswire/ -- 10x Genomics,...
NanoString Provides Preliminary Financial and Operational Highlights for Third Quarter of 2023
SEATTLE--(BUSINESS WIRE)-- #earnings--NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for discovery and translational research, today reported preliminary financi...
A*STAR's Genome Institute of Singapore, NanoString and Next Level Genomics Establish Joint Lab to Advance Studies of Complex Diseases with Spatial Genomics
SINGAPORE--(BUSINESS WIRE)--A*STAR's Genome Institute of Singapore (GIS), NanoString® Technologies, Inc. (NASDAQ: NSTG), and Next Level Genomics (NLG), today announced the establishment of a joint lab...
10x Wins Injunction From Unified Patent Court Banning Sales of NanoString's CosMx Products in Europe
Second Injunction Issued Against CosMx PLEASANTON, Calif. , Sept. 19, 2023 /PRNewswire/ -- 10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, announced today that the Europ...